Scientific American hosted an event at Morehouse School of Medicine to highlight medical advances in treating sickle cell ...
The sickle cell disease market is anticipated to grow by 2034, driven by advances in disease mechanisms that have yielded new diagnostic and therapeutic approaches, opening the way to more drug ...
Specialist Haematologist Dr. Ansah-Otu Williams has debunked and clarified several myths and misconceptions surrounding sickle cell disease.
The new clinic aims to expand access to specialized care for a community disproportionately affected by sickle cell disease.
Experts call for consistent, specialist care throughout life to prevent complications and improve outcomes for people with ...
Sickle cell disease is associated with chronic oxidative stress, hemolysis, inflammation, and progressive multi--organ injury, including significant cardiopulmonary complications. Mitochondrial ...
Growing Up with Sickle Cell Disease Rialton will be sharing his story on BlackDoctor’s “State of Sickle Cell Disease: ...
Beam Therapeutics Inc. is a Strong Buy with promising trial results, a solid cash runway, and key data updates ahead. Click for this updated look at BEAM stock.
Members of Fulcrum management will be joined by Dr. Sheinei Alan, Director of the Inova Adult Sickle Cell Program and Assistant Professor at UVA School of Medicine, and Dr. Martin Steinberg, Professor ...
As a parent with a child who has sickle cell disease, you are always on high alert. The “what if” stays with me, as it ...
Roseland Community Hospital on Monday celebrated the opening of a new sickle cell treatment clinic.
Sickle Cell Disease (SCD) is a serious inherited blood disorder that affects the structure of haemoglobin, the protein in red blood cells responsible for transporting oxygen throughout the body .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback